The Case for Surgery

  • Claudio Bassi
  • Matilde Bacchion
  • Giovanni Marchegiani
Part of the Medical Radiology book series (MEDRAD)


The treatment of choice for ductal adenocarcinoma of the pancreas has to deal with the symptoms and general clinic conditions of the patients, eventual comorbidities, prognostic factors, and survival expectancy. It is nowadays assumed that radical surgery, once a correct indication for a demolitive intervention is given, is the first therapeutical step to positively influence patient’s long survival, even though a complete recovery can seldom be reached (Sener et al. (1999) J Am Coll Surg 189:1–7).


Pancreatic Cancer Distal Pancreatectomy Obstructive Jaundice Superior Mesenteric Vein Total Pancreatectomy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Aldridge MC, Williamson RCN (1991) Distal pancreatectomy with and without splenectomy. Br J Surg 78:976–979PubMedCrossRefGoogle Scholar
  2. Billings BJ, Christein JD, Harmsen WS, Harrington JR, Chari ST, Que FG, Farnell MB, Nagorney DM, Sarr MG (2005) Quality-of-life after total pancreatectomy: is it really that bad on long-term follow-up? J Gastrointest Surg 9(8): 1059–1067PubMedCrossRefGoogle Scholar
  3. Boss A, Clasen S, Kuczyk M, Anastasiadis A, Schmidt D, Graf H et al (2005) Magnetic resonance-guided percutaneous radiofrequency ablation of renal cell carcinoma: a pilot clinical study. Invest Radiol 40:583–590PubMedCrossRefGoogle Scholar
  4. Breslin TM, Hess KR, Harbison DB et al (2001) Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration. Ann Surg Oncol 8:123–132PubMedCrossRefGoogle Scholar
  5. Butturini G, Stocken DD, Wente MN, Jeekel H, Klinkenbijl JH, Bakkevold KE, Takada T, Amano H, Dervenis C, Bassi C, Büchler MW (2008) Neoptolemos JP; Pancreatic Cancer Meta-Analysis Group in patients with pancreatic cancer: meta-analysis of randomized controlled trials. Arch Surg 143(1):75–83PubMedCrossRefGoogle Scholar
  6. Costamagna G, Alevras P, Palladino F, Rainoldi F, Mutignani M, Morganti A (1999) Endoscopic pancreatic stenting in pancreatic cancer. Can J Gastroenterol 13(6):481–487PubMedGoogle Scholar
  7. Date RS, Siriwardena AK (2005) Radiofrequency ablation of the pancreas. II: Intra-operative ablation of non-resectable pancreatic cancer. A description of technique and initial outcome. JOP 6:588–592PubMedGoogle Scholar
  8. Date RS, McMahon RF, Siriwardena AK (2005) Radiofrequency ablation of the pancreas: definition of optimal thermal kinetic parameters and the effect of simulated portal venous circulation in an ex-vivo porcine model. JOP 6:581–587PubMedGoogle Scholar
  9. Dervenis CG (2000) SD, Avgerinos C, Hatzitheoklitos E. Surgical palliation in unresectable pancreatic cancer. In: Dervenis C, Bassi C (eds) Pancreatic tumors. Georg Thieme, Stuttgart, NY, pp 251–256Google Scholar
  10. Deziel DJ, Wilhelmi B, Staren ED, Doolas A (1996) Surgical palliation for ductal adenocarcinoma of the pancreas. Am Surg 62(7):582–588PubMedGoogle Scholar
  11. Egrari S, O’Connell TX (1995) Role of prophylactic gastroenterostomy for unresectable pancreatic carcinoma. Am Surg 61(10):862–864PubMedGoogle Scholar
  12. Elias D, Baton O, Sideris L, Lasser P, Pocard M (2004) Necrotizing pancreatitis after radiofrequency destruction of pancreatic tumors. Eur J Surg Oncol 30:85–87PubMedCrossRefGoogle Scholar
  13. Falconi M, Hilal MA, Salvia R, Sartori N, Bassi C, Pederzoli P (2004) Prophylactic pylorus-preserving gastric transposition in unresectable carcinoma of the pancreatic head. Am J Surg 187(4):564–566PubMedCrossRefGoogle Scholar
  14. Fernandez-Cruz L (2006) Distal pancreatic resection: technical differences between open and laparoscopic approaches. HPB 8:49–56PubMedCentralPubMedCrossRefGoogle Scholar
  15. Fernandez-Cruz L, Orduna D et al (2005) Distal pancreatectomy: en block splenectomy vs spleen preserving pancreatectomy. HPB (Oxford) 7(2):93–98CrossRefGoogle Scholar
  16. Gananadha S, Wulf S, Morris DL (2004) Safety and efficacy of radiofrequency ablation of brain: a potentially minimally invasive treatment for brain tumors. Minim Invasive Neurosurg 47:325–328PubMedCrossRefGoogle Scholar
  17. Geer RJ, Brennan MF (1993) Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg 165:68–72PubMedCrossRefGoogle Scholar
  18. Goldberg SN, Mallery S, Gazelle GS, Brugge WR (1999) EUS-guided radiofrequency ablation in the pancreas: results in a porcine model. Gastrointest Endosc 50:392–401PubMedCrossRefGoogle Scholar
  19. Heidt DG, Burant C, Simeone DM (2007) Total pancreatectomy: indications, operative technique, and postoperative sequelae. J Gastrointest Surg 11:209–216PubMedCrossRefGoogle Scholar
  20. Hoffman JP, Lipsitz S, Pisanky T et al (1998) Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, respectable adenocarcinoma of the pancreas: an Eastern Cooperative Oncology Group Study. J Clin Oncol 16:317–323PubMedGoogle Scholar
  21. Jaeck D, Boudjema K, Bachellier P, Weber JC, Asensio TE, Wolf P (1998) Exeresi pancreatiche cefaliche: duodeno-cefalo-pancreasectomie (DCP). Encycl Méd Chir (Elsevier, Parigi), Tecniche chirurgiche-Addominale 40-880-B:17Google Scholar
  22. Jaeck D, Boudjema K, Bachellier P, Weber Jc, Asensio TE, Wolf P (1998) Pancreasectomie di sinistra o distali. Encycl Méd Chir (Elsevier, Parigi), Tecniche chirurgiche-Addominale 40-880-D:6Google Scholar
  23. Lencioni R, Crocetti L (2005) A critical appraisal of the literature on local ablative therapies for hepatocellular carcinoma. Clin Liver Dis 9:301–314PubMedCrossRefGoogle Scholar
  24. Lillemoe KD, Sauter PK, Pitt HA, Yeo CJ, Cameron JL (1993) Current status of surgical palliation of periampullary carcinoma. Surg Gynecol Obstet 176(1):1–10PubMedGoogle Scholar
  25. Lillemoe KD, Cameron JL, Hardacre JM, Sohn TA, Sauter PK, Coleman J et al (1999) Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial. Ann Surg 230(3):322–328; discussion 328–330Google Scholar
  26. Luque-de Leon E, Tsiotos GG, Balsiger B, Barnwell J, Burgart LJ, Sarr MG (1999) Staging laparoscopy for pancreatic cancer should be used to select the best means of palliation and not only to maximize the resectability rate. J Gastrointest Surg 3(2):111–117; discussion 117–118Google Scholar
  27. Lygidakis NJ, Sharma SK, Papastratis P, Zivanovic V et al (2007) Microwave ablation in locally advanced pancreatic carcinoma – a new look. Hepatogastroenterology 54(77): 1305–1310PubMedGoogle Scholar
  28. Martel J, Bueno A, Nieto-Morales ML, Ortiz EJ (2009) Osteoid osteoma of the spine: CT-guided monopolar radiofrequency ablation. Eur J Radiol 71(3):564–569Google Scholar
  29. Matsui Y, Nakagawa A, Kamiyama Y et al (2000) Selective thermocoagulation of unresectable pancreatic cancers by using radiofrequency capacitive heating. Pancreas 20:14–20PubMedCrossRefGoogle Scholar
  30. Milicevic M, Bulajic P, Zuvela M, Raznatovic Z, Obradovic V, Lekic N et al (2002) Elective resection of the spleen: Overview for resection techniques and description for a new technique based on radiofrequency coagulation and dissection. Acta Chir Iugosl 49:19–24PubMedCrossRefGoogle Scholar
  31. Muller MW, Friess H, Kleeff J, Dahmen R, Wagner M, Hinz U, Breisch-Girbig D, Buchler MW (2007) Is there still a role for total pancreatectomy? Ann Surg 246:966–975PubMedCrossRefGoogle Scholar
  32. Neoptolemos JP et al (2004) A randomized trial of chemoradiotherapy a nd chemotherapy after resection of pancreatic cancer. N Engl Med 350:1200–1210CrossRefGoogle Scholar
  33. Noguchi M (2003) Minimally invasive surgery for small breast cancer. J Surg Oncol 84:94–101PubMedCrossRefGoogle Scholar
  34. Oettle H, Pelzer U, Stieler J et al (2005) Oxaliplatin/folic acid/5-fluorouracil [24h] (OFF) plus best supportive care versus best supportive care alone (BSC) in second-line therapy of gemcitabine-refractory advance advanced pancreatic cancer (CONKO 003). J Clin Oncol 23:4031CrossRefGoogle Scholar
  35. Pingpank JF, Hoffman JP, Ross EA et al (2001) Effect of preoperative chemoradiation on surgical margin status of resected adenocarcinoma of the pancreas. J Gastrointest Surg 5:121–130PubMedCrossRefGoogle Scholar
  36. Potts JR III, Broughan TA, Hermann RE (1990) Palliative operations for pancreatic carcinoma. Am J Surg 159(1):72–77; discussion 77–78Google Scholar
  37. Quiros RM, Brown KM, Hoffman JP (2007) Neoadjuvant therapy in pancreatic cancer. Cancer Invest 25:267–273PubMedCrossRefGoogle Scholar
  38. Richardson DQ, Scott-Conner CEH (1989) Distal pancreatectomy with and without splenectomy. Am Surg 55:21–25PubMedGoogle Scholar
  39. Roost HM, Ackermann C, Harder F (1989) Palliative biliodigestive anastomosis in non-resectable cancer of the head of the pancreas–with or without preventive gastroenterostomy? Helv Chir Acta 55(5):619–621PubMedGoogle Scholar
  40. Sarfeh IJ, Rypins EB, Jakowatz JG, Juler GL (1988) A prospective, randomized clinical investigation of cholecystoenterostomy and choledochoenterostomy. Am J Surg 155(3): 411–414PubMedCrossRefGoogle Scholar
  41. Schantz SP, Schickler W, Evans TK, Coffey RJ (1984) Palliative gastroenterostomy for pancreatic cancer. Am J Surg 147(6): 793–796PubMedCrossRefGoogle Scholar
  42. Schmidt CM, Glant J, Winter JM, Dixon J, Zhao Q, Howard TJ, Madura JA, Nakeeb A, Pitt HA, Cameron JL, Yeo CJ, Lillemoe KD (2007) Total pancreatectomy (R0 resection) improves survival over subtotal pancreatectomy in isolated neck margin positive pancreatic adenocarcinoma. Surgery 142(4):572–578PubMedCrossRefGoogle Scholar
  43. Schwarz A, Beger HG (2000) Biliary and gastric bypass or stenting in nonresectable periampullary cancer: analysis on the basis of controlled trials. Int J Pancreatol 27(1):51–58PubMedCrossRefGoogle Scholar
  44. Sener SF, Fremgen A, Menck HR, Winchester DP (1999) Pancreatic cancer: a report of treatment and survival trends for 100, 313 patients diagnosed from 1985–1995, using the National Cancer Database. J Am Coll Surg 189:1–7PubMedCrossRefGoogle Scholar
  45. Shariat SF, Raptidis G, Masatoschi M, Bergamaschi F, Slawin KM (2005) Pilot study of radiofrequency interstitial tumor ablation (RITA) for the treatment of radio-recurrent prostate cancer. Prostate 65:260–267PubMedCrossRefGoogle Scholar
  46. Simon CJ, Dupuy DE (2005) Current role of image-guided ablative therapies in lung cancer. Expert Rev Anticancer Ther 5:657–666PubMedCrossRefGoogle Scholar
  47. Slim K, Pezet D, Riff Y, Richard JF, Chipponi J (1996) [Antral exclusion. A complement to palliative gastrojejunal shunt in pancreatic cancer]. Presse Med 25(14):674–676PubMedGoogle Scholar
  48. Smith AC, Dowsett JF, Russell RC, Hatfield AR, Cotton PB (1994) Randomised trial of endoscopic stenting versus surgical bypass in malignant low bileduct obstruction. Lancet 344(8938):1655–1660PubMedCrossRefGoogle Scholar
  49. Sohn TA, Lillemoe KD, Cameron JL, Huang JJ, Pitt HA, Yeo CJ (1999) Surgical palliation of unresectable periampullary adenocarcinoma in the 1990s. J Am Coll Surg 188(6):658–666; discussion 666–669Google Scholar
  50. Sohn TA, Yeo CJ, Cameron JL et al (2000) Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 4:567–579PubMedCrossRefGoogle Scholar
  51. Spiliotis JD, Datsis AC, Michalopoulos NV, Kekelos SP, Vaxevanidou A et al (2007) Radiofrequency ablation combined with palliative surgery may prolong survival of patients with advanced cancer of the pancreas. Langenbecks Arch Surg 392:55–60PubMedCrossRefGoogle Scholar
  52. Spitz FR, Abruzzese JL, Lee JE et al (1997) Preoperative and postoperative chemoradiation strategies in patients treated with Pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol 15:928–937PubMedGoogle Scholar
  53. Talamonti MS, Small W Jr, Mulchay MF et al (2006) A multi-institutional phase II trial of preoperative full-dose gemcitabine and concurrent and concurrent radiation for patients with potentially respectable pancreatic carcinoma. Ann Surg Oncol 13:150–158PubMedCrossRefGoogle Scholar
  54. Tao KS, Lu YG, Dou KF (2002) Palliative operation procedures for pancreatic head carcinoma. Hepatobiliary Pancreat Dis Int 1(1):133–136PubMedGoogle Scholar
  55. Trede M (1985) The surgical treatment of pancreatic carcinoma. Surgery 97(1):28–35PubMedGoogle Scholar
  56. Varadhachary GR, Tamm EP, Abruzzese JL et al (2006) Borderline respectable pancreatic cancer: definitions, management, and role of preoperative therapy. Ann Surg Oncol 13: 1035–1046PubMedCrossRefGoogle Scholar
  57. Varshney S, Sewkani A, Sharma S, Kapoor S, Naik S et al (2006) Radiofrequency ablation of unresectable pancreatic carcinoma: feasibility, efficacy and safety. JOP 7:74–78PubMedGoogle Scholar
  58. Wagner M, Redaelli C, Lietz M, Seiler CA, Friess H, Buchler MW (2004) Curative resection ist he single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg 91:586–594PubMedCrossRefGoogle Scholar
  59. Weaver DW, Wiencek RG, Bouwman DL, Walt AJ (1987) Gastrojejunostomy: is it helpful for patients with pancreatic cancer? Surgery 102(4):608–613PubMedGoogle Scholar
  60. White RR, Hurwitz HI, Morse MA et al (2001) Neoadjuvant chemoradiation for localized adenocarcinoma of the pancreas. Ann Surg Oncol 8:758–765PubMedCrossRefGoogle Scholar
  61. Wollf RA, Evans DB, Crane CH et al (2002) Initial results of preoperative gemcitabine (GEM)-based chemoradiation for respectable pancreatic adenocarcinoma. Proc Am Soc Clin Oncol 21:abstract 516Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2010

Authors and Affiliations

  • Claudio Bassi
    • 1
  • Matilde Bacchion
    • 1
  • Giovanni Marchegiani
    • 1
  1. 1.Department of RadiologyPoliclinico “GB Rossi”, University of VeronaVeronaItaly

Personalised recommendations